The DOI matches its Crossref record; 52 of the 60 references it cites were found in a registry or an index.
Brca1 Controls Homology-Directed DNA Repair
Open accessAbstract
Germline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRCA1 in tumor suppression is not yet understood, but both transcription and repair functions have been ascribed. Evidence that BRCA1 is involved in DNA repair stems from its association with RAD51, a homolog of the yeast protein involved in the repair of DNA double-strand breaks (DSBs) by homologous recombination. We report here that Brca1-deficient mouse embryonic stem cells have impaired repair of chromosomal DSBs by homologous recombination. The relative frequencies of homologous and nonhomologous DNA integration and DSB repair were also altered. The results demonstrate a caretaker role for BRCA1 in preserving genomic integrity by promoting homologous recombination and limiting mutagenic nonhomologous repair processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor complex BRCA1-BARD1 functions in DNA double-strand break repair by homologous recombination.”
From BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing (2017) · cites this paper as [18]
Citations
Cites
3 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
Self-citationRetractedCressman, V. L., Backlund, D. C., Avrutskaya, A. V., Leadon, S. A., Godfrey, V., & Koller, B. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7061 · Cited by 108
Self-citationRetractedLeadon, S. A., & Avrutskaya, A. V. (1997) · PubMed · Cited by 78
RetractedThe double-strand-break repair model for recombination
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., & Stahl, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90331-8 · Cited by 2,437
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Self-citationKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Cited by
Sorted by citations
Items 301–400 of 999
DNA double-strand break repair and chromosome translocations
Agarwal, S., Tafel, A. A., & Kanaar, R. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.029 · Cited by 118
BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks
Westermark, U., Reyngold, M., Olshen, A. B., Baer, R. J., Jasin, M., & Moynahan, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7926-7936.2003 · Cited by 120
Self-citationPML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1
Xu, Z., Timanova-Atanasova, A., Zhao, R., & Chang, K.-S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4247-4256.2003 · Cited by 114
BRCA1 : mechanisms of inactivation and implications for management of patients
Kennedy, R. D., Quinn, J. E., Johnston, P. G., & Harkin, D. P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11087-7 · Cited by 116
CtIP-mediated resection is essential for viability and can operate independently of BRCA1
Polato, F., Callén, E., Wong, N., Faryabi, R. B., Bunting, S. F., Chen, H. T., Kozak, M., Kruhlak, M. J., Reczek, C. R., Lee, W., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131939 · Cited by 123
Zhuang, J., Zhang, J., Willers, H., Wang, H., Chung, J. H., van Gent, D. C., Hallahan, D. E., Powell, S. N., & Xia, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3278 · Cited by 119
New complexities for BRCA1 and BRCA2
Kerr, P., & Ashworth, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00389-x · Cited by 117
BRCA1 methylation: a significant role in tumour development?
Catteau, A., & Morris, J. R. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00056-1 · Cited by 121
Puppe, J., Drost, R., Liu, X., Joosse, S. A., Evers, B., Cornelissen‐Steijger, P., Nederlof, P. M., Yu, Q., Jonkers, J., van Lohuizen, M., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2354 · Cited by 117
Role of homologous recombination in carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00010-8 · Cited by 114
Arun, B., Akar, U., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., & Özpolat, B. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3003 · Cited by 115
Targeting homologous recombination repair defects in cancer
Evers, B., Helleday, T., & Jonkers, J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.001 · Cited by 115
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
Moynahan, M. E. (2002) · Oncogene · doi:10.1038/sj.onc.1206177 · Cited by 114
Self-citationPredictive biomarkers for cancer therapy with PARP inhibitors
Michels, J., Vitale, I., Saparbaev, M. K., Castedo, M., & Kroemer, G. (2013) · Oncogene · doi:10.1038/onc.2013.352 · Cited by 117
Huber, L. J., Yang, T. W., Sarkisian, C. J., Master, S. R., Deng, C., & Chodosh, L. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4005-4015.2001 · Cited by 112
Kumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110
DNA double-strand break repair signalling: The case of RAD51 post-translational regulation
Daboussi, F., Dumay, A., Delacôte, F., & López, B. S. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00052-9 · Cited by 107
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 109
The role of BRCA1 in DNA double-strand repair: Past and present
Caestecker, K. W., & Van de Walle, G. R. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.013 · Cited by 108
Kass, E. M., Helgadottir, H. R., Chen, C.-C., Barbera, M. A., Wang, R., Westermark, U., Ludwig, T., Moynahan, M. E., & Jasin, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216824110 · Cited by 110
Self-citationBRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
Aly, A., & Ganesan, S. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq055 · Cited by 116
Cell-cycle responses to DNA damage in G2
Cuddihy, A. R., & O'Connell, M. J. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(02)22013-6 · Cited by 89
Razandi, M., Pedram, A., Rosen, E. M., & Levin, E. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5900-5913.2004 · Cited by 108
Making the best of PARP inhibitors in ovarian cancer
Banerjee, S. N., Kaye, S. B., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.116 · Cited by 107
Broering, T. J., Alavattam, K. G., Sadreyev, R. I., Ichijima, Y., Kato, Y., Hasegawa, K., Camerini‐Otero, R. D., Lee, J. T., Andreassen, P. R., & Namekawa, S. H. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201311050 · Cited by 100
RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance
Wang, Y., Krais, J. J., Bernhardy, A. J., Nicolas, É., Cai, K. Q., Harrell, M. I., Kim, H. H., George, E. M., Swisher, E. M., Simpkins, F. A., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87033 · Cited by 110
Goldberg, M. S., Xing, D., Ren, Y., Oršulić, S., Bhatia, S. N., & Sharp, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016538108 · Cited by 107
Cousineau, I., Abaji, C., & Belmaaza, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2156 · Cited by 108
HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response
Lee, Y.-H., Kuo, C., Stark, J. M., Shih, H., & Ann, D. K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt231 · Cited by 116
Assessment of functional effects of unclassified genetic variants
Couch, F. J., Rasmussen, L. J., Hofstra, R. M. W., Monteiro, Á. N. A., Greenblatt, M. S., de Wind, N., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20899 · Cited by 111
Wang, H., Chou, W., Shieh, S.-Y., & Shen, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3270 · Cited by 109
Conte, G. D., Sessa, C., von Moos, R., Viganò, L., Digena, T., Locatelli, A., Gallerani, E., Fasolo, A., Tessari, A., Cathomas, R. L., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.345 · Cited by 104
Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 103
Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
Arizti, P., Li, F., Park, I., Yin, Y., Solomon, E., Ouchi, T., Aaronson, S. A., & Lee, S. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7450-7459.2000 · Cited by 102
Kim, B., Jeong, Y. E., Wong, M., & Martin, L. J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0874-4 · Cited by 109
Xu, X. L., Wu, L. C., Du, F., Davis, A., Peyton, M., Tomizawa, Y., Maitra, A., Tomlinson, G. E., Gazdar, A. F., Weissman, B. E., et al. (2001) · PubMed · Cited by 103
Schlegel, B. P., Starita, L. M., & Parvin, J. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206195 · Cited by 102
Elledge, S. J., & Amon, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00041-7 · Cited by 100
BRCA1 Promotes Induction of ssDNA by Ionizing Radiation
Schlegel, B. P., Jodelka, F. M., & Núñez, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3209 · Cited by 107
How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
Venkitaraman, A. R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102668 · Cited by 111
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
Wu, Q., Siddharth, S., & Sharma, D. (2021) · Cancers · doi:10.3390/cancers13153697 · Cited by 110
The Fanconi road to cancer: Figure 1.Preprint
D’Andrea, A. D. (2003) · Genes & Development · doi:10.1101/gad.1128303 · Cited by 99
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Prokhorova, E. A., Zobel, F., Smith, R., Zentout, S., Gibbs‐Seymour, I., Schützenhofer, K., Peters, A., Groslambert, J., Zorzini, V., Agnew, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24361-9 · Cited by 102
O’Regan, P., Wilson, C. R., Townsend, S., & Thacker, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102396200 · Cited by 99
A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining
Baldeyron, C., Jacquemin, E., Smith, J., Jacquemont, C. F., Oliveira, I. D., Gad, S., Feunteun, J., Stoppa‐Lyonnet, D., & Papadopoulo, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205200 · Cited by 99
BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells
Aprelikova, O. N., Pace, A. J., Fang, B. S., Koller, B. H., & Liu, E. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100265200 · Cited by 99
Self-citationNacson, J., Krais, J. J., Bernhardy, A. J., Clausen, E., Feng, W., Wang, Y., Nicolas, É., Cai, K. Q., Tricarico, R., Hua, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.086 · Cited by 99
PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA
Risdon, E. N., Chau, C. H., Price, D. K., Sartor, O. A., & Figg, W. D. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0697 · Cited by 104
DNA damage responses and their many interactions with the replication fork
Andreassen, P. R., Ho, G. P. H., & D’Andrea, A. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi319 · Cited by 99
Cavallo, F., Graziani, G., Antinozzi, C., Feldman, D. R., Houldsworth, J., Bosl, G. J., Chaganti, R. S. K., Moynahan, M. E., Jasin, M., & Barchi, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051563 · Cited by 98
Self-citationCheng, W.-H., Kusumoto, R., Opresko, P. L., Sui, X., Huang, S., Nicolette, M. L., Paull, T. T., Campisi, J., Seidman, M. M., & Bohr, V. A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl362 · Cited by 98
BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites
Patel, D. S., Misenko, S. M., Her, J., & Bunting, S. F. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201703144 · Cited by 98
Negative Cell Cycle Regulation and DNA Damage-inducible Phosphorylation of the BRCT Protein 53BP1
Xia, Z., Morales, J. C., Dunphy, W. G., & Carpenter, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007665200 · Cited by 96
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy
Haince, J.-F., Rouleau, M., Hendzel, M. J., Masson, J., & Poirier, G. G. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.003 · Cited by 98
Han, J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh002 · Cited by 96
BRCA1 and BRCA2 mutations and the risk for colorectal cancer
Sopik, V., Phelan, C., Cybulski, C., & Narod, S. A. (2014) · Clinical Genetics · doi:10.1111/cge.12497 · Cited by 95
Deans, B., Griffin, C. S., O’Regan, P., Jasin, M., & Thacker, J. (2003) · PubMed · Cited by 95
Self-citationBRC‐1 acts in the inter‐sister pathway of meiotic double‐strand break repair
Adamo, A., Montemauri, P., Silva, N., Ward, J. D., Boulton, S. J., & Volpe, A. L. (2008) · EMBO Reports · doi:10.1038/sj.embor.7401167 · Cited by 92
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Shimelis, H., Mesman, R. L. S., Nicolai, C. V., Ehlén, Å., Guidugli, L., Martin, C. A., Calléja, F. M. G. R., Meeks, H., Hallberg, E., Hinton, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2568 · Cited by 96
DNA repair and damage pathways in breast cancer development and therapy
Majidinia, M., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.009 · Cited by 92
Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor α Activity
Wang, C., Fan, S., Li, Z., Fu, M., Rao, M., Ma, Y., Lisanti, M. P., Albanese, C., Katzenellenbogen, B. S., Kushner, P. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0486 · Cited by 93
The role of the DNA double-strand break response network in meiosis
Richardson, C. A., Horikoshi, N., & Pandita, T. K. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.05.007 · Cited by 94
Homologous recombination proficiency in ovarian and breast cancer patients
Creeden, J. F., Nanavaty, N. S., Einloth, K. R., Gillman, C. E., Stanbery, L., Hamouda, D., Dworkin, L. D., & Nemunaitis, J. J. (2021) · BMC Cancer · doi:10.1186/s12885-021-08863-9 · Cited by 96
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Xiong, J., Fan, S., Meng, Q., Schramm, L., Wang, C., Bouzahza, B., Zhou, J., Zafonte, B. T., Goldberg, I. D., Haddad, B. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8668-8690.2003 · Cited by 96
DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein
Pichierri, P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2531 · Cited by 90
Replication and recombination intersect
Marians, K. J. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00059-9 · Cited by 91
Transcriptional Regulation of the Base Excision Repair Pathway by BRCA1
Saha, T., Rih, J. K., Roy, R., Ballal, R. D., & Rosen, E. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104430 · Cited by 93
Opposing roles for 53BP1 during homologous recombination
Kakarougkas, A., Ismail, A., Klement, K., Goodarzi, A. A., Conrad, S., Freire, R., Shibata, A., Löbrich, M., & Jeggo, P. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt729 · Cited by 98
Targeting the DNA damage response for cancer therapy
Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86
Goldmann, J. M., Seplyarskiy, V. B., Wong, W. S. W., Vilboux, T., Neerincx, P. B. T., Bodian, D. L., Solomon, B. D., Veltman, J. A., Deeken, J. F., Gilissen, C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0071-6 · Cited by 89
Recombination: a frank view of exchanges and vice versa
Haber, J. E. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00090-9 · Cited by 89
BACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
Wang, Q., Zhang, H., Fishel, R. A., & Greene, M. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203974 · Cited by 87
Distinct functions of BRCA1 and BRCA2 in double-strand break repair
Liu, Y., & West, S. C. (2001) · Breast Cancer Research · doi:10.1186/bcr417 · Cited by 87
Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers
Dréan, A., Williamson, C. T., Brough, R., Brandsma, I., Menon, M. R., Konde, A., García-Murillas, I., Pemberton, H. N., Frankum, J. R., Rafiq, R., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0098 · Cited by 84
Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects
Bishop, A. J. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2427 · Cited by 86
BRCA1: exploring the links to transcription
Monteiro, Á. N. A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01632-7 · Cited by 87
Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair
Somyajit, K., Subramanya, S., & Nagaraju, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311241 · Cited by 88
Molecular Functions of BRCA1 in the DNA Damage Response
Scully, R., Xie, A., & Nagaraju, G. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.842 · Cited by 85
Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1
Fan, S., Yuan, R., Ma, Y. X., Meng, Q., Goldberg, I. D., & Rosen, E. M. (2001) · Oncogene · doi:10.1038/sj.onc.1205033 · Cited by 85
When Genome Maintenance Goes Badly Awry
Kass, E. M., Moynahan, M. E., & Jasin, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.021 · Cited by 84
Self-citationCellular senescence and DNA repair
Lou, Z., & Chen, J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.009 · Cited by 82
DNA double-strand break signaling and human disorders
Bohgaki, T., Bohgaki, M., & Hakem, R. (2010) · Genome Integrity · doi:10.1186/2041-9414-1-15 · Cited by 95
Paull, T. T. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.015 · Cited by 90
BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells
Grotsky, D. A., González-Suárez, I., Novell, A., Neumann, M. A., Yaddanapudi, S. C., Croke, M., Martínez‐Alonso, M., Redwood, A. B., Ortega‐Martínez, S., Feng, Z., et al. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201204053 · Cited by 89
DNA Damage Induces p53-dependent BRCA1 Nuclear Export
Feng, Z., Kachnic, L. A., Zhang, J., Powell, S. N., & Xia, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404137200 · Cited by 85
Billing, D. L., Horiguchi, M., Wu-Baer, F., Taglialatela, A., Leuzzi, G., Nanez, S. A., Jiang, W., Zha, S., Szabolcs, M. J., Lin, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.016 · Cited by 86
Shang, Y. L., Bodero, A. J., & Chen, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210749200 · Cited by 82
BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation
Chen, X., Arciero, C. A., Wang, C., Broccoli, D., & Godwin, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4194 · Cited by 82
Ye, L., Wang, C., Hong, L., Sun, N., Chen, D., Chen, S., & Han, F. (2018) · Cell Discovery · doi:10.1038/s41421-018-0049-7 · Cited by 83
Reczek, C. R., Szabolcs, M. J., Stark, J. M., Ludwig, T., & Baer, R. J. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201302145 · Cited by 89
Polymorphisms in DNA repair and environmental interactions
de Boer, J. G. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00217-8 · Cited by 81
Bertrand, P., Lambert, S., Joubert, C., & López, B. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206998 · Cited by 80
Evers, B., Schut, E., van der Burg, E., Braumuller, T. M., Egan, D. A., Holstege, H. H., Edser, P. A. H., Adams, D. J., Wade‐Martins, R., Bouwman, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2434 · Cited by 78
Scarbrough, P. M., Weber, R. P., Iversen, E. S., Brhane, Y., Amos, C. I., Kraft, P. L., Hung, R. J., Sellers, T. A., Witte, J. S., Pharoah, P. D. P., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0649 · Cited by 82
Somasundaram, K. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10469 · Cited by 78
Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA
Morimoto, S., Tsuda, M., Bunch, H., Sasanuma, H., Austin, C. A., & Takeda, S. (2019) · Genes · doi:10.3390/genes10110868 · Cited by 84
BRCA1 tumor suppressor network: focusing on its tail
Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
Alaofi, R. K., Nassif, M. O., & Al‐Hajeili, M. (2018) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_21_18 · Cited by 78
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
Mamdani, H. M., & Jalal, S. I. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.582370 · Cited by 81
Metadata
- Authors
- Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Jasin, Maria
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-10
- Volume
- 4
- Issue
- 4
- Pages
- 511-518
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2059365987
- Cited by
- 1,245
- References
- 60
- Citations by year
- 2026: 27 · 2025: 18 · 2024: 22 · 2023: 35 · 2022: 21 · 2021: 42 · 2020: 47 · 2019: 48 · 2018: 53 · 2017: 47 · 2016: 47 · 2015: 45 · 2014: 55 · 2013: 58 · 2012: 47
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Cancer Institute (1P50CA68425, P50CA068425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, homologous recombination, homology-directed repair, DNA double-strand break repair, RAD51, non-homologous end joining, genome stability, tumor suppression, mouse embryonic stem cells, germline mutations, breast and ovarian cancer
- MeSH terms
- Animals, Arabinofuranosyluracil, Cell Line, Chromosomes, DNA Damage, DNA Repair, DNA-Binding Proteins, Mutation, Proto-Oncogene Proteins, Recombination, Genetic, Stem Cells, Thymidine Kinase, Transfection, Retinoblastoma Protein, Mice, Knockout, Gene Targeting, BRCA1 Protein, Rad51 Recombinase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review